June 23, 2022 3-6PM CEST, 9-12AM EDT, 6-9 AM PDT. Register here.
In 2019, 1.27 million deaths were attributable to antimicrobial resistance (AMR) and 4.95 million deaths were associated with AMR.
Vaccines can prevent a proportion of the AMR burden by:
- preventing drug-sensitive and drug-resistant infections
- reducing antibiotic use
- reducing pathogen transmission and opportunity to develop or acquire resistance genes
Increasing evidence from observational and modelling studies show the impact of vaccines on AMR. However, this evidence is yet to translate to policy and decision making about which vaccines to develop and introduce so they effectively prevent AMR.
This webinar will explore the mechanisms, evidence and value of vaccines in preventing AMR. A panel of experts will discuss what are the challenges to ensure that vaccines to prevent AMR are developed and widely used.